Unknown Infection Site
Community or Hospital Acquired, Past History of Infection with MRSA (or Intravascular Catheter in Place) and ESBL Producing Organism
Severity(classification)
|
1st line oral/iv antibiotics
|
Penicillin allergy (see explanatory notes)
|
A/B/C
Grading not applicable
Review doses in renal impairment
|
MEROPENEM 1g iv tds
plus
TEICOPLANIN 400mg iv every 12 hours for 3 doses then 600mg iv once daily Maintain treatment pending pre-dose (trough) level on Day 5
Mild to moderate infection (10-20mg/L) Severe(>20mg/L , <60mg/L)
Re-assay after 6 to 8 days (assay details)
Review initial therapy within 24 hrs. If a source of infection becomes apparent use the appropriate antibiotic guideline. Modify therapy based on results of microbiological or other investigations. Discuss with microbiologist if required.
|
AMIKACIN 15mg/kg iv od (max 1.5g od) Only if serum creatinine <150micromol/L.
Maintain pre-dose (trough) serum level <5mg/l
plus
TEICOPLANIN 400mg iv every 12 hours for 3 doses then 600mg iv once daily
Maintain treatment pending pre-dose (trough) level on Day 5
Mild to moderate infection (10-20mg/L) Severe(>20mg/L , <60mg/L)
Re-assay after 6 to 8 days (assay details)
OR if AMIKACIN is contra-indicated (see local policy):
DISCUSS WITH MICROBIOLOGIST
|
For guidance on the administration of intravenous antibiotics click here
(GHNHSFT intranet)